Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor ("TKI”) being jointly developed and commercialized by AstraZeneca and HUTCHMED. In 2023, savolitinib and TAGRISSO ® ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

Discover how diet affects lung cancer risk. Learn about the link between a high-fat, high-sugar diet and lung cancer ...

Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

Longtime Rep. Raul Grijalva, D-Ariz. passed away at 77 years old on Thursday after a battle with lung cancer.

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

In this cohort study, geographic access to cancer care was associated with guideline-recommended treatment for early-stage non–small cell lung cancer (NSCLC) and outcomes, particularly in socially ...